Venkatesan Jay
- SEC CIK
- 0001413350
In the past year, 1 open-market purchase filing worth $1.05K and no sales.
Current role at each company
- ELTX Elicio Therapeutics, Inc.Directoras of Sep 2, 2026
- SER Serina Therapeutics, Inc.Directoras of Jun 22, 2026
- ALPN Alpine Immune Sciences, Inc.Director, 10% Owneras of Jul 19, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $1.05K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$1.05K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Venkatesan Jay as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SER Serina Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 (view filing) | May 22 | 31 daysLate | Venkatesan JayDirector | PPurchase | +589 | $1.78 | +$1.05K | New position589 after |
ELTX Elicio Therapeutics, Inc.
Director9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 (view filing) | Jun 28, 2024 | 188 days | Venkatesan JayDirector | PPurchase | +100.0K | $2.50 | +$249.5K | –50.0K after | AmendedDerivative2 lots |
| Jul 2, 2024 (view filing) | Jun 28 | 4 days | Venkatesan JayDirector | PPurchase | +300.0K | $2.50 | +$748.5K | –50.0K after | From originalDerivative6 lots |
| May 27, 2022 (view filing) | Feb 9, 2021 | 472 days | Venkatesan JaySee Remarks | SSale | −159.2K | $16.00 | −$2.55M | −10.4%1.37M after | Amended |
| May 27, 2022 (view filing) | May 25 | 2 days | Venkatesan JaySee Remarks | PPurchase | +11.3K | $1.25 | +$14.1K | +0.6%1.89M after | |
| May 25, 2022 (view filing) | May 20-24 | 5 daysLate | Venkatesan JaySee Remarks | PPurchase | +82.2K | $1.23 | +$101.4K | +5.0%1.72M after | 2 lots |
| Dec 29, 2021 (view filing) | Dec 27-28 | 2 days | Venkatesan JaySee Remarks | PPurchase | +277.2K | $2.63 | +$730.1K | +20.4%1.64M after | 2 lots |
| Dec 22, 2021 (view filing) | Dec 20 | 2 days | Venkatesan JaySee Remarks | PPurchase | +3.53K | $2.54 | +$8.96K | +0.3%1.36M after | |
| Dec 20, 2021 (view filing) | Dec 16-17 | 4 days | Venkatesan JaySee Remarks | PPurchase | +41.6K | $2.55 | +$106.0K | +3.2%1.36M after | 2 lots |
| Dec 17, 2021 (view filing) | Dec 15 | 2 days | Venkatesan JaySee Remarks | PPurchase | +77.6K | $2.41 | +$187.0K | +6.3%1.32M after |
ALPN Alpine Immune Sciences, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2021 (view filing) | Sep 17 | 4 days | Venkatesan JayDirector, 10% Owner | SSale | −400.0K | $9.40 | −$3.76M | −13.3%2.60M after |